Turalio
Pexidartinib hydrochloride · Daiichi Sankyo Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Turalio ingredients
| Active ingredient | Strength |
|---|---|
| Pexidartinib Hydrochloride | 125 mg/1 |
What Turalio is used for
Turalio is a cancer medicine (kinase inhibitor). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Turalio
- Generic name
- Pexidartinib hydrochloride
- Made by
- Daiichi Sankyo Inc.
- Forms
- Capsule
- Given
- Oral
- Drug class
- Kinase Inhibitor
- FDA approval
- New drug application (NDA) NDA211810
- On the US market since
- 2023
Official information
- Turalio prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Pexidartinib hydrochloride)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Turalio?
Turalio (Pexidartinib hydrochloride) is a cancer medicine made by Daiichi Sankyo Inc., approved by the US FDA.
What are the ingredients of Turalio?
Turalio contains Pexidartinib Hydrochloride (125 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA